Next Article in Journal
Targeted Delivery of VEGF-siRNA to Glioblastoma Using Orientation-Controlled Anti-PD-L1 Antibody-Modified Lipid Nanoparticles
Previous Article in Journal
Polyglutamic Acid as an Antiviral Agent: Mechanistic and Structural Insights
Previous Article in Special Issue
Development of Palatable Amorphous Trazodone Hydrochloride Formulations via Ion Exchange
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(10), 1297; https://doi.org/10.3390/pharmaceutics17101297
Action Date Notes Link
article xml file uploaded 3 October 2025 15:40 CEST Original file -
article xml uploaded. 3 October 2025 15:40 CEST Update -
article pdf uploaded. 3 October 2025 15:40 CEST Version of Record https://www.mdpi.com/1999-4923/17/10/1297/pdf-vor
article html file updated 3 October 2025 15:43 CEST Original file -
article xml file uploaded 7 October 2025 09:55 CEST Update -
article xml uploaded. 7 October 2025 09:55 CEST Update https://www.mdpi.com/1999-4923/17/10/1297/xml
article pdf uploaded. 7 October 2025 09:55 CEST Updated version of record https://www.mdpi.com/1999-4923/17/10/1297/pdf
article html file updated 7 October 2025 09:57 CEST Update https://www.mdpi.com/1999-4923/17/10/1297/html
Back to TopTop